For the first time, members of the media had a chance to tour the Sanofi Pasteur facility in Swiftwater, Monroe County. Sanofi is one of five manufacturers in the world to make the swine flu vaccine and the only one in the United States to make the …
Read Original Story: Coming Up: News 8 Tours Swine Flu Vaccine Production Facility – WGAL
CAMBRIDGE, Mass., Nov 10 (Reuters) – Production of H1N1swine flu vaccine at two facilities in Pennsylvania is "working optimally," with output on the rise, the chief executive of Sanofi-Aventis SA (SASY.PA) said on Tuesday. …
Read Original Story: Sanofi CEO-US H1N1 vaccine output rising quickly – Reuters
The vaccines unit of French pharmaceutical company Sanofi-Aventis SA (SNY, SAN.FR) confirmed the initial analysis of its H1N1 vaccine in both adults and children. The company had said the product produced a "robust" immune response on adult test …
Read Original Story: Sanofi Confirms Safety, Effectiveness of Its H1N1 Vaccine – Wall Street Journal
Chris Viehbacher, the CEO of Sanofi-Aventis, told the Health Blog a while back that he planned to shift a big chunk of research funding away from Sanofi’s internal labs and toward external partnerships with smaller, …
Read Original Story: Sanofi's Research Shift: Billion-Dollar Deal, Venture Capital Fund – Wall Street Journal (blog)
Who’s at fault for the slow-to-market H1N1 vaccine? USA Today asked consumers, and more than half of them blamed drug companies. Some 62 percent said they blame pharma either a great deal or moderately. The government, by contrast, got 58 percent of …
Read Original Story: US blames drugmakers for slow flu shots – FiercePharma
Federal Food and Drug Administration Commissioner Margaret Hamburg, MD, has posted an open letter praising doctors, nurses, and other health professionals for their “extraordinary efforts” in responding to the 2009 H1N1 influenza …
Read Original Story: SPECIAL COVERAGE: H1N1 Influenza News – Nurse.com
“We have a footprint here,” Christopher A. Viehbacher, director general of Sanofi-Aventis said. Cambridge is a “hotbed of research activity.” (John Tlumacki/Globe Staff) By Robert Weisman CAMBRIDGE – The top executive of French drug maker …
Read Original Story: French drug maker says it's eager to work with Boston-area companies – Boston Globe
Swiftwater, Pennsylvania (CNN) — Vaccine manufacturing giant Sanofi Pasteur opened its doors to the media Wednesday, inviting reporters to a first-of-its-kind, up-close look at its H1N1 flu vaccine production facility. …
Read Original Story: H1N1 vaccine maker Sanofi Pasteur gives tour to journalists – CNN
Sanofi-Aventis (NYSE: SNY) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why Boston-area biotech companies should want to form partnerships with the French drug giant. It was an impressive show of force by the …
Read Original Story: Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston … – Xconomy
The CDC recommends that every child 9 years and under should get 2 H1N1 influenza vaccines 4 weeks apart to ensure a strong immune response if the child is exposed to H1N1. However with shortages in H1N1 flu vaccines that goal seems less obtainable and …
Read Original Story: Parents worry kids won't get second H1N1 vaccine – Examiner.com
